Peg-interferon alpha and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients

被引：0
|
作者：
Pawelczyk, T. [1 ]
Pawelczyk, A. [2 ]
Strzelecki, D. [1 ]
Bialkowska, J. [3 ]
Jablkowski, M. [3 ]
Dworniak, D. [3 ]
Rabe-Jablonska, J. [1 ]
机构：
[1] Med Univ Lodz, Dept Affect Psychot Disorders & Adolescent Psychi, Lodz, Poland
[2] SPZOZ PaLMA, Outpatient Psychiat Clin, Lodz, Poland
[3] Med Univ Lodz, Dept Infect Dis, Lodz, Poland
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2007年 / 17卷
关键词：
D O I：
10.1016/S0924-977X(07)70814-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S526 / S527
页数：2
相关论文
共 50 条
  • [41] Double filtration plasmapheresis and (PEG) interferon/ribavirin combination therapy in chronic hepatitis C patients
    Ide, T.
    Kaneko, S.
    Kakumu, S.
    Mochida, S.
    Sata, M.
    Fujiwara, K.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S227 - S228
  • [42] Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C
    Lens, Sabela
    Calleja, Jose L.
    Campillo, Ana
    Carrion, Jose A.
    Broquetas, Teresa
    Perello, Christie
    de la Revilla, Juan
    Marino, Zoe
    Londono, Maria-Carlota
    Sanchez-Tapias, Jose M.
    Urbano-Ispizua, Alvaro
    Forns, Xavier
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (17) : 5421 - 5426
  • [43] Chronic hepatitis C and Crohn's disease:: Nosocomial infection treatment with PEG-interferon plus ribavirin
    Salcedo-Mora, Xamila
    Mate, Jose
    Medina, Jesus
    Chab, Syong J. Nam
    Gisbert, Javier P.
    Moreno-Otero, Ricardo
    DIGESTION, 2006, 73 (04) : 210 - 214
  • [44] Treatment outcomes to Peg-interferon and ribavirin in a government sponsored clinic for an underserved population with chronic hepatitis C
    Iturrino, Johanna
    Romero, Carlos J.
    Sanchez, Carlos J.
    Velazquez, Vanessa
    Ortiz, Adelaida
    Costas, Pablo J.
    Torres, Esther A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S412 - S412
  • [45] Danazol in the treatment of thrombocytopenia associated with the use of peg-interferon alfa 2a and Ribavirin in patients with chronic hepatitis C
    Gomez-Galicia, Diana
    Cabrera-Alvarez, Guillermo
    Rodriguez-Fragoso, Lourdes
    Reyes-Esparza, Jorge
    FASEB JOURNAL, 2010, 24
  • [46] Adherence to therapy enhances sustained response in chronic hepatitis C patients receiving peg-interferon alfa-2b plus ribavirin
    McHutchison, J
    Manns, M
    Harvey, J
    Albrecht, JK
    JOURNAL OF HEPATOLOGY, 2001, 34 : 2 - 3
  • [47] Immune alterations and profile of lymphocyte subsets in treatment resistant chronic hepatitis C patients, after PEG-interferon plus ribavirin combination therapy
    Macedo, G
    Lopes, S
    Ramos, JP
    Araujo, F
    Veloso, FT
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S90 - S90
  • [48] Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse
    Lagging, Martin
    Rembeck, Karolina
    Buhl, Mads Rauning
    Christensen, Peer
    Dalgard, Olav
    Farkkila, Martti
    Hellstrand, Kristoffer
    Langeland, Nina
    Lindh, Magnus
    Westin, Johan
    Norkrans, Gunnar
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2013, 48 (07) : 839 - 847
  • [49] Peg-interferon plus ribavirin in chronic hepatitis C: cost-efficacy and pharmacoutilization in clinical practice
    Cavalletto, Luisa
    Bernardinello, Elisabetta
    Diodati, Giulio
    Raise, Enzo
    Gatta, Angelo
    Chemello, Liliana
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2008, 9 (04) : 173 - 181
  • [50] Bilateral AION after the combined therapy of hepatitis C with PEG-interferon α2B and ribavirin
    Kirchhoff, A
    Kirchhoff, U
    Lafrenz, M
    Guthoff, R
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2004, 221 (09) : 791 - 793
12345